Cerebrolysin is safe and improves both cognition and clinical functioning in patients with moderate to moderate/severe vascular dementia, according to trial data presented here at the 9th International Conference on Alzheimer's and Parkinson's Diseases.
Cerebrolysin improves cognition and clinical functioning in patients with moderate to moderate/severe vascular dementia: